Vol:23 | No:04 - DiabetesontheNet

This site is intended for healthcare professionals only

Diabetes &
Primary Care

Vol:23 | No:04
Oct 2023

Filter:

Editorial: Why does discussing lifestyle seem more difficult than prescribing drugs?

Although lifestyle change is the cornerstone of type 2 diabetes management, why is it so challenging to discuss in clinics?

Page: 93

Drugs in development and new data on established drugs: Highlights from the American Diabetes Association 81st Scientific Sessions

Pam Brown highlights the key findings from ADA 2021 and relates them to current clinical practice.

Page: 115

Diabetes Distilled: AMPLITUDE-O: Increasing the wavelength of the GLP-1 RA class

New exendin-based, once-weekly GLP-1 RA efpeglenatide significantly improves cardiovascular and renal outcomes.

Page: 125

Interactive case study: Hypoglycaemia and type 2 diabetes

Four new mini-scenarios to improve our knowledge and problem-solving skills.

Page: 113

Introducing a new e-learning resource exploring the nine care processes recommended for good diabetes management in primary care

Introducing the PCDS Entry Level Module series on the nine care processes recommended by NICE.

Page: 101

Diabetes Distilled: Who DAREs wins. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19

DARE-19: Dapagliflozin safe and effective for non-critically ill people with COVID-19.

Page: 128

Request for poster abstracts

Readers are invited to submit poster abstracts for the 17^th National Conference of the PCDS.

Page: 123

Diabetes Distilled: Missed opportunities: Statins underprescribed in ethnic minorities

Equalising ethnic differences in initiation would reduce cardiovascular events in people with type 2 diabetes.

Page: 127

PCDS Committee elections (2021): Call for candidates

Details of the call for candidates for the upcoming PCDS Committee elections.

Page: 121

Interactive case study: Steroid-induced hyperglycaemia

Improve your knowledge of steroid-induced hyperglycaemia: three mini-scenarios to consider.

Page: 111

How to assess feet to prevent foot ulceration in people with diabetes

A step-by-step guide to improving foot care for people with diabetes.

Page: 105

Diabetes Distilled: Tirzepatide versus semaglutide – the SURPASS-2 study

New dual GIP/GLP-1 receptor agonist shows superior HbA1c and weight reductions to semaglutide in open-label trial.

Page: 126

How to diagnose and manage erectile dysfunction in men with diabetes

Diagnosing and managing this complication that affects over 50% of men with diabetes.

Page: 109

At a glance factsheet: GLP-1 receptor agonists and diabetic retinopathy

The evidence regarding diabetic retinopathy in users of GLP-1 receptor agonists, plus recommendations on safe use.

Page: 103

The role of digital diabetes education (MyDESMOND) during the COVID-19 pandemic

How this structured education programme for people with type 2 diabetes has been adapted for online use, and its outcomes since the start of the pandemic.

Page: 97

LATEST ARTICLES

At a glance factsheet: Newer lipid-lowering therapies in type 2 diabetes

Diabetes Distilled: Earlier diabetes, earlier death

test

At a glance factsheet: Impaired hypoglycaemia awareness

Diabetes Distilled: Albuminuria – population screening is feasible but targeted screening is better

Editorial: Little chance of a summer lull this year!

Overview of the NHS Type 2 Diabetes Path to Remission Programme

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;